Title : Evaluating perceived cognition and daily performance in individuals newly diagnosed with cancer pre-chemotherapy
Abstract:
Impairments in cognition and difficulties in daily functioning are common among individuals with cancer following chemotherapy. While most studies focus on cognition and daily functioning post-chemotherapy, few have assessed individuals newly diagnosed with cancer before chemotherapy begins.
This study aims to:
1.Evaluate the perceived cognition and daily performance of individuals newly diagnosed with cancer.
2.Explore whether participants recognize cognitive difficulties that may impact their daily performance before chemotherapy commences.
Using a mixed-methods approach, we collected qualitative and quantitative data before and after chemotherapy. This presentation focuses on pre-chemotherapy findings. Participants included adults newly diagnosed with non-central nervous system malignancies (stages I-III). The Canadian Occupational Performance Measure (COPM) was used to assess daily performance (3-5 goals per participant), while the Perceived Cognitive Impairment (FACT-PCI) scale measured cognitive difficulties. Additionally, qualitative data were gathered through open-ended questions regarding cognitive impairments and their impact on daily performance.
In this ongoing study, 11 participants (8 women) aged 60±6.6 years have been included so far. Among the COPM goals, 74% related to instrumental activities of daily living (IADL), 48% to basic ADL (BADL), 37% to family relationships, and 30% to leisure activities. The median COPM performance score was 8.6 (IQR: 6.4-10) out of 10, with three participants (27%) reporting lower performance scores (<6/10). The median FACT-PCI score of 47 (IQR: 25.7-53.2) out of 72 suggests that cognitive difficulties were experienced approximately 2-3 times per week. Interestingly, most participants did not recognize cognitive difficulties as limiting their daily performance.
These preliminary findings indicate that while some cognitive impairments are perceived pre-chemotherapy, daily performance remains largely preserved. However, participants’ lack of awareness regarding cognitive difficulties highlights the need for further assessment. As data collection continues, post-chemotherapy evaluations will provide further insights into cognitive changes and their impact on daily life.
